Infant risk of pulmonary hypertension from maternal antidepressants appears small

A new cohort study examining Medicaid‐insured pregnant women has found a smaller risk of persistent pulmonary hypertension of the newborn (PPHN) from women's late‐term use of antidepressants than what had been seen in earlier research. The latest findings add further context to a topic that has been greatly discussed since the Food and Drug Administration (FDA) in 2006 issued a public health advisory on PPHN risk associated with late exposure to selective serotonin reuptake inhibitors (SSRIs). Study results were published June 2, 2015, in the Journal of the American Medical Association.
Source: The Brown University Psychopharmacology Update - Category: Psychiatry Tags: Antidepressant Treatment Source Type: research